Evaluation of the novel avocado/soybean unsaponifiable Arthrocen to alter joint pain and inflammation in a rat model of osteoarthritis.
PLOS One. 2018 February
Goudarzi R1, Reid A2, McDougall JJ2.
1Division of Research and Development, Pharmin USA, LLC, San Jose, California, United States of America.
2Departments of Pharmacology and Anaesthesia, Pain Management & Perioperative Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Effects of Arthrocen, an avocado/soy unsaponifiables agent, on inflammatory mediators and gene expression in human chondrocytes.
FEBS Open Bio. 2017 January.
Goudarzi R1, Taylor JF2, Yazdi PG2, Pedersen BA3
1Pharmin USA, LLC San Jose CA USA.
2Systomic Health Los Angeles CA USA.
3Division of Rheumatology, Allergy and Immunology,
Department of Medicine University of California - San Diego, La Jolla, CA USA
In Vitro Effects of Arthrocen, an Avocado/Soy Unsaponifiables Agent, on Inflammation and Global Gene Expression in Human Monocytes.
International Journal of Chemistry. 2017 January.
Taylor JF1, Goudarzi R2, Yazdi PG1, Pedersen BA3.
1Systomic Health, USA.
2Division of Research and Development, Pharmin USA, LLC, USA.
3Department of Medicine, Division of Rheumatology, Allergy and Immunology, University of California, San Diego, USA.
Management of Osteoarthritis with Avocado/Soybean Unsaponifiables.
Cartilage. 2015 January
Christiansen BA1, Goudarzi R2, Emami S3.
1University of California-Davis Health System, Department of Orthopaedic Surgery, Lawrence J. Ellison Musculoskeletal Research Center, 4635 2nd Ave, Suite 2000, Sacramento, CA 95817.
2Pharmin USA, LLC, San Jose, California, United States of America
3Corresponding author